CN104958365B - 糖尿病辅助治疗饮液及其制备方法 - Google Patents
糖尿病辅助治疗饮液及其制备方法 Download PDFInfo
- Publication number
- CN104958365B CN104958365B CN201510318578.6A CN201510318578A CN104958365B CN 104958365 B CN104958365 B CN 104958365B CN 201510318578 A CN201510318578 A CN 201510318578A CN 104958365 B CN104958365 B CN 104958365B
- Authority
- CN
- China
- Prior art keywords
- parts
- days
- fresh lotus
- fresh
- slurries
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010012601 Diabetes mellitus Diseases 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 86
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 84
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 84
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 238000000855 fermentation Methods 0.000 claims abstract description 27
- 230000004151 fermentation Effects 0.000 claims abstract description 27
- 239000002002 slurry Substances 0.000 claims abstract description 24
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 21
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 19
- 235000012907 honey Nutrition 0.000 claims abstract description 16
- 239000012141 concentrate Substances 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 239000004480 active ingredient Substances 0.000 claims abstract description 6
- 238000004140 cleaning Methods 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 239000003814 drug Substances 0.000 abstract description 16
- 238000001816 cooling Methods 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 2
- 239000008280 blood Substances 0.000 description 26
- 210000004369 Blood Anatomy 0.000 description 25
- 210000003734 Kidney Anatomy 0.000 description 10
- 239000008103 glucose Substances 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='300px' height='300px' viewBox='0 0 300 300'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='300.0' height='300.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-0 atom-1' d='M 46.2,132.4 L 54.0,143.9' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-0 atom-0 atom-1' d='M 54.0,143.9 L 61.8,155.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-2 atom-1' d='M 113.1,151.7 L 61.5,150.3 L 62.2,160.6 Z' style='fill:#3B4143;fill-rule:evenodd;fill-opacity:1;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-2 atom-2 atom-3' d='M 113.1,151.7 L 119.3,139.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 119.3,139.0 L 125.4,126.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-10 atom-2' d='M 142.0,194.2 L 113.1,151.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 153.2,104.1 L 170.0,102.9' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 170.0,102.9 L 186.8,101.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-4 atom-5' d='M 186.8,101.7 L 192.9,89.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-4 atom-5' d='M 192.9,89.0 L 199.1,76.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-4 atom-6' d='M 186.8,101.7 L 215.6,144.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 222.4,144.7 L 222.3,142.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 229.2,145.3 L 228.9,141.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 236.0,145.8 L 235.5,139.7' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 242.8,146.3 L 242.2,138.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 249.6,146.9 L 248.8,136.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-6 atom-8' d='M 215.6,144.2 L 193.2,190.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 193.2,190.5 L 200.1,205.2 L 204.4,202.3 Z' style='fill:#3B4143;fill-rule:evenodd;fill-opacity:1;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-8 atom-8 atom-9' d='M 200.1,205.2 L 215.5,214.1 L 207.0,219.9 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-8 atom-8 atom-9' d='M 200.1,205.2 L 204.4,202.3 L 215.5,214.1 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-9 atom-8 atom-10' d='M 193.2,190.5 L 142.0,194.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 138.2,199.7 L 140.0,200.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 134.4,205.1 L 138.1,206.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 130.6,210.6 L 136.2,213.3' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 126.8,216.1 L 134.2,219.7' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 123.0,221.5 L 132.3,226.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='13.6' y='123.2' class='atom-0' style='font-size:20px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='26.8' y='123.2' class='atom-0' style='font-size:20px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='129.3' y='115.7' class='atom-3' style='font-size:20px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='203.0' y='65.7' class='atom-5' style='font-size:20px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='217.2' y='65.7' class='atom-5' style='font-size:20px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='260.7' y='150.7' class='atom-7' style='font-size:20px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='274.9' y='150.7' class='atom-7' style='font-size:20px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='215.9' y='243.3' class='atom-9' style='font-size:20px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='230.1' y='243.3' class='atom-9' style='font-size:20px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='100.3' y='250.8' class='atom-11' style='font-size:20px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='113.4' y='250.8' class='atom-11' style='font-size:20px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
</svg>
 data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='85px' height='85px' viewBox='0 0 85 85'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='85.0' height='85.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-0 atom-1' d='M 11.0,34.7 L 14.0,39.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-0 atom-0 atom-1' d='M 14.0,39.1 L 17.0,43.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-2 atom-1' d='M 31.5,42.5 L 16.9,42.1 L 17.1,45.0 Z' style='fill:#3B4143;fill-rule:evenodd;fill-opacity:1;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-2 atom-2 atom-3' d='M 31.5,42.5 L 33.9,37.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 33.9,37.6 L 36.3,32.7' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-10 atom-2' d='M 39.7,54.5 L 31.5,42.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 40.1,29.2 L 46.2,28.8' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 46.2,28.8 L 52.4,28.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-4 atom-5' d='M 52.4,28.3 L 54.8,23.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-4 atom-5' d='M 54.8,23.4 L 57.1,18.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-4 atom-6' d='M 52.4,28.3 L 60.6,40.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 64.8,40.5 L 64.7,39.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 68.9,40.7 L 68.8,38.8' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 73.1,40.9 L 72.9,38.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-6 atom-8' d='M 60.6,40.4 L 54.3,53.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 54.3,53.5 L 57.0,58.8 L 58.2,58.0 Z' style='fill:#3B4143;fill-rule:evenodd;fill-opacity:1;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-8 atom-8 atom-9' d='M 57.0,58.8 L 62.2,62.5 L 59.8,64.2 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-8 atom-8 atom-9' d='M 57.0,58.8 L 58.2,58.0 L 62.2,62.5 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-9 atom-8 atom-10' d='M 54.3,53.5 L 39.7,54.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 37.5,58.0 L 38.4,58.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 35.3,61.4 L 37.1,62.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 33.1,64.8 L 35.7,66.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='3.2' y='34.5' class='atom-0' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='7.0' y='34.5' class='atom-0' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='36.1' y='32.4' class='atom-3' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='57.0' y='18.2' class='atom-5' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='61.1' y='18.2' class='atom-5' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='73.3' y='42.3' class='atom-7' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='77.5' y='42.3' class='atom-7' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='60.6' y='68.5' class='atom-9' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='64.8' y='68.5' class='atom-9' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='27.7' y='70.6' class='atom-11' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='31.6' y='70.6' class='atom-11' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
</svg>
 OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 210000004072 Lung Anatomy 0.000 description 8
- 210000000952 Spleen Anatomy 0.000 description 8
- 210000002216 Heart Anatomy 0.000 description 6
- 210000002784 Stomach Anatomy 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 229940079593 drugs Drugs 0.000 description 6
- 230000023597 hemostasis Effects 0.000 description 5
- 210000004185 Liver Anatomy 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 230000000740 bleeding Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 235000021271 drinking Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000004634 feeding behavior Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 235000015203 fruit juice Nutrition 0.000 description 4
- 230000001737 promoting Effects 0.000 description 4
- 210000001124 Body Fluids Anatomy 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010018987 Haemorrhage Diseases 0.000 description 3
- 208000008466 Metabolic Disease Diseases 0.000 description 3
- 230000036740 Metabolism Effects 0.000 description 3
- 231100000614 Poison Toxicity 0.000 description 3
- 231100000319 bleeding Toxicity 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 201000008286 diarrhea Diseases 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 230000003902 lesions Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000035786 metabolism Effects 0.000 description 3
- 210000000056 organs Anatomy 0.000 description 3
- 230000001225 therapeutic Effects 0.000 description 3
- 208000001848 Dysentery Diseases 0.000 description 2
- 210000001508 Eye Anatomy 0.000 description 2
- 210000000936 Intestines Anatomy 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 210000004304 Subcutaneous Tissue Anatomy 0.000 description 2
- 230000001684 chronic Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001114 myogenic Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000002035 prolonged Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 210000000697 sensory organs Anatomy 0.000 description 2
- 231100000486 side effect Toxicity 0.000 description 2
- 230000002269 spontaneous Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000001015 Abdomen Anatomy 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000002399 Aphthous Stomatitis Diseases 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 210000004204 Blood Vessels Anatomy 0.000 description 1
- 210000000988 Bone and Bones Anatomy 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 241000668709 Dipterocarpus costatus Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 210000002683 Foot Anatomy 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010018830 Haematemesis Diseases 0.000 description 1
- 206010018836 Haematochezia Diseases 0.000 description 1
- 208000006750 Hematuria Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000002287 Hemorrhoids Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010062060 Hyperlipidaemia Diseases 0.000 description 1
- 206010000546 Metabolism disorder Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 210000003205 Muscles Anatomy 0.000 description 1
- 206010029410 Night sweats Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 241000209477 Nymphaeaceae Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037211 Psychomotor hyperactivity Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000005687 Scabies Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 210000003491 Skin Anatomy 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- 210000004243 Sweat Anatomy 0.000 description 1
- 210000002435 Tendons Anatomy 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010068760 Ulcers Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 229930013930 alkaloids Natural products 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary Effects 0.000 description 1
- 201000010870 diseases of metabolism Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000020828 fasting Nutrition 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 229930003944 flavones Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000002218 hypoglycaemic Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000002503 metabolic Effects 0.000 description 1
- 230000003020 moisturizing Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001105 regulatory Effects 0.000 description 1
- 230000003014 reinforcing Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 230000003393 splenic Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000002142 suicide Effects 0.000 description 1
- 201000010874 syndrome Diseases 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Abstract
本发明公开了一种糖尿病辅助治疗饮液及其制备方法，其有效成分包括有下列重量份的原料制成：鲜莲藕430～450，鲜莲藕节340～360，鲜莲房300～320，鲜荷叶240～250，干五味子60～70，带芯鲜莲子70～80，蜂蜜200～220。制备方法包括如下步骤：A、将鲜荷叶和干五味子用冷水浸泡放水煎煮，浓缩至浓缩液；冷却48天～50天；B、将洗净晾干的鲜莲藕、鲜莲藕节、鲜莲房、带芯鲜莲子混合加水粉碎；C、再加入蜂蜜放入容器在发酵；D、将步骤A获得的浓缩液和步骤C获得的浆液混合，再密封发酵150天～180天即可。本发明可以解决现有治疗糖尿病的药物长期服用影响患者生活质量和寿命的问题。
Description
糖尿病辅助治疗饮液及其制备方法
技术领域
[0001] 本发明涉及糖尿病辅助治疗技术领域，尤其是一种对糖尿病患者有辅助治疗作用 的保健饮用液及其制备方法。
背景技术
[0002] 糖尿病是一组以高血糖为特征的代谢性疾病，高血糖则是由于胰岛素分泌缺陷或 其生物作用受损，或两者兼有引起，糖尿病时长期存在的高血糖，导致各种组织，特别是眼、 肾、心脏、血管、神经的慢性损害、功能障碍。糖尿病的治疗一般都需要用降糖药物或中药进 行长期的或者是终身的治疗，而糖尿病患者长期服用药物会导致身体其他器官的不适，对 肝肾仍形成较大的负担，且易产生抗药性，引起其他并发症，既影响生活质量，又影响人的 寿命。因而需要研发一种对人身体无副作用的，并且可以在治疗疾病中平衡人的身体各个 器官及系统正常循环的饮液配合药物服用，以降低长期服用药物对人体带来的副作用。
发明内容
[0003] 本发明所要解决的问题是提供一种糖尿病辅助治疗饮液及其制备方法，以解决现 有治疗糖尿病的药物长期服用影响患者生活质量和寿命的问题。
[0004] 为了解决上述问题，本发明的技术方案是:本糖尿病辅助治疗饮液其有效成分包 括有下列重量份的原料制成:鲜莲藕430〜450,鲜莲藕节340〜360,鲜莲房300〜320,鲜荷 叶240〜250，干五味子60〜70，带芯鲜莲子70〜80，蜂蜜200〜220。
[0005] 鲜莲藕节，味甘、涩，性平；归肝、肺、胃经，体质坚，可散可收；具有收敛止血的功 效。藕节收敛之中兼能活血祛瘀，止血而无留瘀之弊。藕节可用于治疗吐血、衄血等多种出 血证。藕节长于止血，兼能散瘀。用于衂血、咳血、吐血、便血、尿血和妇女崩漏，以失血而有 癖血者最为适宜。
[0006] 鲜莲藕，味甘，性凉，主补中焦，养神，益气力。能清热生津，凉血止血，散瘀血。熟用 微温，能补益脾胃，止泻，益血，生肌。补中养神，除百病。常服，轻身耐老，延年益寿。补益十 二经脉血气，平体内阳热过盛、火旺。交心肾，厚肠胃，固精气，强筋骨，补虚损，利耳目，并除 寒湿，止脾泄久痢，女子非经期出血过多等症。生食过多，微动气。捣碎和米煮粥饭食，使人 强健，蒸食也好。大便燥涩的人不能吃之。莲是益脾之果。
[0007] 鲜荷叶，性味苦涩，平，归肝、脾、胃、心经。有清暑利湿、升发清阳、凉血止血等功 效。中提取的生物碱及黄酮制成浸膏片，临床应用后有降血脂和降胆固醇的作用，已用于治 疗尚脂血症、肥胖症、脂肪肝等病症。
[0008] 莲房，又名：莲蓬壳，为睡莲科植物莲的成熟花托。味苦性涩湿，归足厥阴肝经，分 血，治血崩，月经过多，胎漏下血，瘀血腹痛，产后胎衣不下，血痢，血淋，痔疮脱肛，皮肤湿 疮。为散瘀治带药，可预防糖尿病。
[0009] 五味子，性温味酸，归肺、肾、心、经，具敛肺、滋肾、生津、收汗、涩精的功效。治肺虚 喘咳，口干作渴，自汗，盗汗，劳伤羸瘦，梦遗滑精，久泻久痢。保固元气而无遗泄也。然在上 入肺，在下入肾，入肺有生津济源之益，入肾有固精养髓之功。
[0010] 莲子，味甘、涩，性平，归脾、肾、心经。具补脾止泻，止带，益肾涩精，养心、安神的功 效。莲之味甘，气温而性涩，禀清芳之气，得稼穑之味，乃脾之果也。土为元气之母，母气既 和，津液相成，神乃自生，久视耐老，以其权舆也。昔人治心肾不交，劳伤白浊，有清心莲子 饮;补心肾，益精血，有瑞莲丸，皆得此理。
[0011] 蜂蜜，味甘;性平；归脾经、胃经、肺经、大肠经;调补脾胃；缓急止痛;润肺止咳；润 肠通便；润肤生肌;解毒。主脘腹虚痛;肺燥咳嗽;肠燥便秘；目赤；口疮;溃疡不敛;风瘆瘙 痒;水火烫伤;手足皲裂。治疗胃、十二指肠溃疡。
[0012] 为了解决上述问题，本发明的技术方案还包括:本糖尿病辅助治疗饮液的制备方 法包括如下步骤：
[0013] A、将240份〜250份的鲜荷叶和60份〜70份的干五味子用冷水浸泡50分钟〜60分 钟后滤干，放入鲜荷叶和干五味子总重量的3倍的水煎煮，煎煮三次，三次煎煮时间为1.3小 时〜1.5小时，将三次收集到的水煎液合并，40°C〜50°C温度下浓缩至相对密度为1.1〜1.2 浓缩液;置于-15 °C〜-8 °C的温度下存放48天〜50天；
[0014] B、将洗净晾干的430份〜450份的鲜莲藕、340份〜360份的鲜莲藕节、300份〜320 份的鲜莲房、70份〜80份的带芯鲜莲子混合形成混合物，放入粉碎机中，再加入3.2〜3.4倍 于上述混合物的水混合粉碎成浆液，过滤，过滤后，所述浆液中的颗粒的直径尺寸在800目 〜850目之间；所述水为矿泉水或通过水厂处理过的自来水；
[0015] C、将步骤B获得的浆液加入200份〜220份的蜂蜜放入容器在25 °C〜35 °C的温度下 发酵30天，发酵期间将容器压力过大时的气体放出；之后进行密封发酵145天〜160天，密封 发酵温度为20°C〜30°C;
[0016] D、将步骤A获得的浓缩液和步骤C获得的浆液混合，再密封发酵150天〜180天即 可;发酵温度为20°C〜30°C。如此制备出来的糖尿病辅助治疗饮，根据个人口味及习惯，可 以稀释50倍〜10倍当饮料饮用，味道酸爽，如饮果汁，每日本糖尿病辅助治疗饮的饮用量为 20晕升，最尚不超过30晕米。
[0017] 糖尿病，即代谢病，即人类长期饮食及作息不当导致的代谢紊乱，在中医称之消渴 证，本糖尿病辅助治疗饮液中以鲜莲藕节和鲜莲房为君药，莲的其他部分，鲜荷叶和鲜带芯 莲子为辅，理血养阴清浊治疗糖尿病，五味子固本培元，补先天之本，提高人的机体免疫力， 提升各种代谢功能，蜂蜜滋补，既调和百药，又调节脾胃以补后天之本;莲花的整个植株，被 古代中医认为是比较特殊的植株，从根至花，其归经覆盖了人体的主要筋脉，其寒热也相互 制约平衡，是少见的五行生灭平衡的植株，本方选用莲植株的主要部分作为主要原料，清而 不寒，补而燥，五行平衡，自动平衡代谢，对糖尿病等代谢失调病尤为有效，且取自自然食 材，以食代药，可以长期大量服用，无其他中药制剂的药性过烈或过偏导致身体其他脏腑器 官的失衡。
[0018] 本方法采用鲜的植物莲为主，发酵成小分子，协调平衡体内的各种代谢，包括糖代 谢，同时也分解掉药物残留物，减少药物的对人体产生的副作用；特殊小大的鲜莲藕等碎 粒，在液体中悬浮，既增加了美观和食欲，又含有一定的纤维素，以增强糖尿病人的血糖中 的糖类代谢;荷叶和五味子在蒸煮后，会增加燥热，利于人体，中医称之为“火毒”，在特殊低 温下存放超过一定时间，以解“火毒”，以致温而不燥，适合人体长期大量的服用。
具体实施方式
[0019] 下面对本发明实施例作进一步详述：
[0020] 实施例一：
[0021] 本糖尿病辅助治疗饮液其有效成分包括有下列重量份的原料制成:鲜莲藕430,鲜 莲藕节360，鲜莲房300，鲜荷叶250，干五味子60，带芯鲜莲子80，蜂蜜200。
[0022] 本糖尿病辅助治疗饮液的制备方法，包括如下步骤：
[0023] A、将250份的鲜荷叶和60份的干五味子用冷水浸泡50分钟后滤干，放入鲜荷叶和 干五味子总重量的3倍的水煎煮，煎煮三次，三次煎煮时间依次为1.5小时、1.4小时、1.3小 时，将三次收集到的水煎液合并，45 °C〜50 °C温度下浓缩至相对密度为1.1浓缩液;置于-15 °C〜_12°C的温度下存放49天;B、将洗净晾干的430份的鲜莲藕、360份的鲜莲藕节、300份的 鲜莲房、80份的带芯鲜莲子混合形成混合物，放入粉碎机中，再加入3.3倍于上述混合物的 水混合粉碎成浆液，浆液中的颗粒的直径尺寸在800目〜850目之间;所述水为矿泉水;C、将 步骤B获得的浆液加入200份蜂蜜放入容器在25 °C〜35 °C的温度下发酵30天，发酵期间将容 器压力过大时的气体放出；之后进行密封发酵145天，密封发酵温度为20 °C〜30°C;D、将步 骤A获得的浓缩液和步骤C获得的浆液混合，再密封发酵150天即可；发酵温度为20°C〜30 °C。如此制备出来的糖尿病辅助治疗饮，根据个人口味及习惯，可以稀释50倍〜10倍当饮料 饮用，味道酸爽，如饮果汁，每日本糖尿病辅助治疗饮的饮用量为20毫升，最高不超过30毫 米;也可以作为下次制备的发酵剂使用，在步骤C中加入浆液和蜂蜜总量的0.5%至1%的本饮 液即可。
[0024] 实施例二：
[0025] 本糖尿病辅助治疗饮液其有效成分包括有下列重量份的原料制成:鲜莲藕450,鲜 莲藕节350，鲜莲房320，鲜荷叶245，干五味子70，带芯鲜莲子75，蜂蜜220。
[0026] 本糖尿病辅助治疗饮液的制备方法，包括如下步骤：
[0027] A、将245份的鲜荷叶和70份的干五味子用冷水浸泡55分钟后滤干，放入鲜荷叶和 干五味子总重量的3倍的水煎煮，煎煮三次，三次煎煮时间依次为1.5小时、1.4小时、1.3小 时，将三次收集到的水煎液合并，48 °C〜50 °C温度下浓缩至相对密度为1.2浓缩液;置于-12°C〜_8°C的温度下存放50天;B、将洗净晾干的450份的鲜莲藕、360份的鲜莲藕节、300份 的鲜莲房、70份的带芯鲜莲子混合形成混合物，放入粉碎机中，再加入3.2倍于上述混合物 的水混合粉碎成浆液，过滤，过滤后，所述浆液中的颗粒的直径尺寸在800目〜850目之间； 所述水为通过水厂处理过的自来水;C、将步骤B获得的浆液加入220份的蜂蜜放入容器在25 °C〜35°C的温度下发酵30天，发酵期间将容器压力过大时的气体放出；之后进行密封发酵 160天，密封发酵温度为20°C〜30°C ; D、将步骤A获得的浓缩液和步骤C获得的浆液混合，再 密封发酵180天即可;发酵温度为20°C〜30°C。如此制备出来的糖尿病辅助治疗饮，根据个 人口味及习惯，可以稀释50倍〜10倍当饮料饮用，味道酸爽，如饮果汁，每日本糖尿病辅助 治疗饮的饮用量为20毫升，最高不超过30毫米;也可以作为下次制备的发酵剂使用，在步骤 C中加入浆液和蜂蜜总量的0.5%至1%的本饮液即可。
[0028] 实施例三：
[0029] 本糖尿病辅助治疗饮液其有效成分包括有下列重量份的原料制成:鲜莲藕440,鲜 莲藕节340，鲜莲房310，鲜荷叶240，干五味子65，带芯鲜莲子70，蜂蜜210。
[0030] 本糖尿病辅助治疗饮液的制备方法，包括如下步骤：
[0031] A、将240份的鲜荷叶和65份的干五味子用冷水浸泡60分钟后滤干，放入鲜荷叶和 干五味子总重量的3倍的水煎煮，煎煮三次，三次煎煮时间依次为1.5小时、1.4小时、1.3小 时，将三次收集到的水煎液合并，40 °C〜45 °C温度下浓缩至相对密度为1.15浓缩液;置于-15 °C〜-10 °C的温度下存放48天;B、将洗净晾干的440份的鲜莲藕、340份的鲜莲藕节、310份 的鲜莲房、70份的带芯鲜莲子混合形成混合物，放入粉碎机中，再加入3.4倍于上述混合物 的水混合粉碎成浆液，过滤，过滤后，所述浆液中的颗粒的直径尺寸在800目〜850目之间； 所述水为矿泉水;C、将步骤B获得的浆液加入210份的蜂蜜放入容器在25°C〜35°C的温度下 发酵30天，发酵期间将容器压力过大时的气体放出；之后进行密封发酵160天，密封发酵温 度为20°C〜30°C ; D、将步骤A获得的浓缩液和步骤C获得的浆液混合，再密封发酵170天即 可;发酵温度为20°C〜30°C。如此制备出来的糖尿病辅助治疗饮，根据个人口味及习惯，可 以稀释50倍〜10倍当饮料饮用，味道酸爽，如饮果汁，每日本糖尿病辅助治疗饮的饮用量为 20毫升，最高不超过30毫米;也可以作为下次制备的发酵剂使用，在步骤C中加入浆液和蜂 蜜总量的0.5%至1%的本饮液即可。
[0032] 实施例一至实施例三的临床疗效观察。
[0033] 病例资料:全部病例均符合1999年WHO糖尿病诊断标准，确诊为糖尿病患者400例， 并知情同意参加实验。随机分为两组，试验组230例，在药物治疗的基础上，给予实施例一至 实施例三的饮液，根据个人口味及习惯，稀释50倍〜10倍内服，每日饮液量20毫升;对照组 170例，给于药物治疗。治疗期限5年，观察期5年。两组患者均为男性216人，女性184人，年龄 均在30至60岁之间，试验组与对照组对比，差异无统计学意义(P>0.05)。
[0034] 治疗标准:参照《中医新药临床研究指导原则》拟定。显效：临床症状消失，血糖恢 复至正常范围内或血糖较治疗前下降30%以上;有效：临床症状明显改善，血糖较治疗前下 降20%以上;无效:临床症状及身体各项指标均无改善。
[0035] 表1为两组患者试验结果比较
[0036]
[0037] 从表1中可以看出，试验组显效率为85.65%，有效率为13.91%，显效率和有效率之 和超过了 99%。对照组显效率为32.94%，有效率为30.00%，无效率为37.06%。从而可见试验组 的治疗效果明显优于对照组。说明本方法所得饮液对辅助治疗糖尿病有显著疗效。
[0038] 表2为两组患者治疗如后空腹血糖、餐后2h血糖及血红蛋白Aic的比车父
[0039]
[0040] 从表2中可以看出，治疗后，两组患者的血糖均较治疗前明显下降P〈0.05，两组治 疗后血糖各项指标，试验组患者平均血糖各项指标水平明显低于对照组患者的平均血糖各 项指标水平P〈〇.05。可以得出结论，试验组血糖改善情况明显优于对照组。
Claims (1)
1. 一种糖尿病辅助治疗饮液的制备方法，其特征在于：其有效成分包括有下列重量份 的原料制成:鲜莲藕430〜450,鲜莲藕节340〜360,鲜莲房300〜320,鲜荷叶240〜250,干五 味子60〜70，带芯鲜莲子70〜80，蜂蜜200〜220; 包括如下步骤： A、 将240份〜250份的鲜荷叶和60份〜70份的干五味子用冷水浸泡50分钟〜60分钟后 滤干，放入鲜荷叶和干五味子总重量的3倍的水煎煮，煎煮三次，三次煎煮时间为1.3小时〜 1.5小时，将三次收集到的水煎液合并，40°C〜50°C温度下浓缩至相对密度为1.1〜1.2浓缩 液;置于-15 °C〜-8 °C的温度下存放48天〜50天； B、 将洗净晾干的430份〜450份的鲜莲藕、340份〜360份的鲜莲藕节、300份〜320份的 鲜莲房、70份〜80份的带芯鲜莲子混合形成混合物，放入粉碎机中，再加入3.2〜3.4倍于上 述混合物的水混合粉碎成浆液，过滤，过滤后，所述浆液中的颗粒的直径尺寸在800目〜850 目之间;所述水为矿泉水或通过水厂处理过的自来水； C、 将步骤B获得的浆液加入200份〜220份的蜂蜜放入容器在25°C〜35°C的温度下发酵 30天，发酵期间将容器压力过大时的气体放出；之后进行密封发酵145天〜160天，密封发酵 温度为20°C〜30°C; D、 将步骤A获得的浓缩液和步骤C获得的浆液混合，再密封发酵150天〜180天即可;发 酵温度为20°C〜30°C。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510318578.6A CN104958365B (zh) | 2015-06-11 | 2015-06-11 | 糖尿病辅助治疗饮液及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510318578.6A CN104958365B (zh) | 2015-06-11 | 2015-06-11 | 糖尿病辅助治疗饮液及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104958365A CN104958365A (zh) | 2015-10-07 |
| CN104958365B true CN104958365B (zh) | 2017-12-26 |
Family
ID=54212570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510318578.6A Expired - Fee Related CN104958365B (zh) | 2015-06-11 | 2015-06-11 | 糖尿病辅助治疗饮液及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104958365B (zh) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102559461A (zh) * | 2012-02-17 | 2012-07-11 | 张昂 | 一种莲酒及其生产工艺 |
-
2015
- 2015-06-11 CN CN201510318578.6A patent/CN104958365B/zh not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102559461A (zh) * | 2012-02-17 | 2012-07-11 | 张昂 | 一种莲酒及其生产工艺 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104958365A (zh) | 2015-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104719535A (zh) | 一种改善女性亚健康状态的玛卡黑茶组合物及制备方法 | |
| CN103417837B (zh) | 一种药食两用的枸杞养生膏及其制备方法 | |
| CN102987477B (zh) | 一种保健饮料 | |
| CN102342506B (zh) | 一种能防治糖尿病的食疗组合物及其制作方法 | |
| CN101347253B (zh) | 一种补钙保健悬浮饮料及其制备方法 | |
| CN108277138A (zh) | 一种保健养生酒及其制备方法 | |
| CN106490558A (zh) | 一种保健蜂蜜及其制备方法 | |
| CN104856036A (zh) | 治疗缺铁性贫血的保健药膳及制法 | |
| CN102579906B (zh) | 一种具有开胃醒酒作用的药品或者保健食品 | |
| CN104958436A (zh) | 高血压辅助治疗饮液及其制备方法 | |
| CN104673573B (zh) | 适用于糖尿病病人服用的葡萄酒及制备方法 | |
| CN103392855A (zh) | 健脾统血保健茶膏及制备方法 | |
| CN104687133A (zh) | 一种鹿茸补肾虚强身汤料的配方及生产方法 | |
| CN107281390A (zh) | 一种用于养生保健的中药组合物及其制备方法 | |
| CN104958365B (zh) | 糖尿病辅助治疗饮液及其制备方法 | |
| CN102988747B (zh) | 一种三刺降三高的冲剂及其制备方法 | |
| CN104305193A (zh) | 具有促进肠推进作用的食品及其制备方法 | |
| CN104922381B (zh) | 胃溃疡辅助治疗饮液及其制备方法 | |
| CN106344655A (zh) | 一种具有降血糖功效的中药组合物及其制作方法 | |
| CN107149670A (zh) | 治疗糖尿病的药茶及其制备方法 | |
| CN106361982A (zh) | 一种治疗糖尿病的药食两用中药制剂及其制备方法 | |
| CN106359737A (zh) | 一种蜂蜜红茶及其制备方法 | |
| CN106072157A (zh) | 一种降糖保健食品及其制备方法 | |
| CN105249089A (zh) | 一种土元薏苡仁乳饮料及其制备方法 | |
| CN104940679A (zh) | 一种治疗糖尿病的养生胶囊及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| C06 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20180705 Address after: No. 8 Wenchang Road, Liuzhou, the Guangxi Zhuang Autonomous Region Co-patentee after: Li Jing Patentee after: Liuzhou People's Hospital Address before: 545006 Liuzhou road people's Hospital, 8 Wenchang Road, Liuzhou, the Guangxi Zhuang Autonomous Region. Patentee before: Li Jing |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20171226 Termination date: 20190611 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |